D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 87 Citations 32,481 292 World Ranking 6929 National Ranking 216

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

J. Alfred Witjes spends much of his time researching Bladder cancer, Prostate cancer, Surgery, Magnetic resonance imaging and Cancer. Bladder cancer is a subfield of Internal medicine that J. Alfred Witjes investigates. The Prostate cancer study combines topics in areas such as Prostate, Mr imaging and Nuclear medicine.

His work carried out in the field of Surgery brings together such families of science as Meta-analysis, Cystectomy, Cystoscopy and Urology. Magnetic resonance imaging is a subfield of Radiology that J. Alfred Witjes explores. His Cancer study combines topics from a wide range of disciplines, such as Genome-wide association study and Gynecology.

His most cited work include:

  • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. (1826 citations)
  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995)) (1460 citations)
  • Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. (807 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Bladder cancer, Urology, Internal medicine, Prostate cancer and Surgery. His Bladder cancer research entails a greater understanding of Cancer. His Cancer research is multidisciplinary, relying on both Odds ratio and Gynecology.

In the subject of general Urology, his work in Urinary bladder is often linked to In patient, thereby combining diverse domains of study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Oncology and Pathology. His research integrates issues of Biopsy, Magnetic resonance imaging, Radiology and Prostate in his study of Prostate cancer.

He most often published in these fields:

  • Bladder cancer (49.56%)
  • Urology (31.78%)
  • Internal medicine (29.74%)

What were the highlights of his more recent work (between 2017-2021)?

  • Bladder cancer (49.56%)
  • Urology (31.78%)
  • Internal medicine (29.74%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Bladder cancer, Urology, Internal medicine, Cystectomy and Cystoscopy. His Bladder cancer research focuses on Non muscle invasive in particular. J. Alfred Witjes combines subjects such as Cancer, Adverse effect, Hyperthermia, Toxicity and Mitomycin C with his study of Urology.

His Internal medicine research focuses on subjects like Oncology, which are linked to Biomarker and Progressive disease. He interconnects Carcinoma in situ, Guideline, Intensive care medicine, Perioperative and General surgery in the investigation of issues within Cystectomy. His studies deal with areas such as Biopsy, Prostate and Confidence interval as well as Prostate cancer.

Between 2017 and 2021, his most popular works were:

  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines (117 citations)
  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). (103 citations)
  • European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. (83 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

J. Alfred Witjes focuses on Bladder cancer, Urology, Cystectomy, Internal medicine and Cystoscopy. His biological study spans a wide range of topics, including Chemotherapy, Cytology, Urine, Disease and Biomarker. Gold standard and Receiver operating characteristic is closely connected to Clinical trial in his research, which is encompassed under the umbrella topic of Urology.

His Cystectomy research integrates issues from Guideline, Perioperative, Randomized controlled trial and Evidence-based medicine. His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Immunotherapy. His research investigates the connection between Cystoscopy and topics such as Confidence interval that intersect with issues in Patient summary and Intravesical chemotherapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Richard J. Sylvester;Adrian P.M. van der Meijden;Willem Oosterlinck;J. Alfred Witjes.
European Urology (2006)

2997 Citations

Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem.
Nature Genetics (2009)

2177 Citations

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

J. Alfred Witjes;Thierry Lebret;Eva M. Compérat;Nigel C. Cowan.
European Urology (2017)

1149 Citations

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

J. Alfred Witjes;Eva Compérat;Nigel C. Cowan;Maria De Santis.
European Urology (2014)

1008 Citations

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Julius Gudmundsson;Patrick Sulem;Andrei Manolescu;Laufey T Amundadottir.
Nature Genetics (2007)

970 Citations

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

Daphne Hessels;Jacqueline M.T. Klein Gunnewiek;Inge van Oort;Herbert F.M. Karthaus.
European Urology (2003)

858 Citations

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

Bas W.G. van Rhijn;Maximilian Burger;Yair Lotan;Eduardo Solsona.
European Urology (2009)

690 Citations

Many sequence variants affecting diversity of adult human height

Daniel F Gudbjartsson;G Bragi Walters;Gudmar Thorleifsson;Hreinn Stefansson.
Nature Genetics (2008)

680 Citations

Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging

Caroline M A Hoeks;Jelle O Barentsz;Thomas Hambrock;Derya Yakar.
Radiology (2011)

674 Citations

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer

Per-Uno Malmström;Richard J. Sylvester;David E. Crawford;Martin Friedrich.
European Urology (2009)

647 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing J. Alfred Witjes

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 357

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 129

Morgan Rouprêt

Morgan Rouprêt

Université Paris Cité

Publications: 129

Yair Lotan

Yair Lotan

The University of Texas Southwestern Medical Center

Publications: 123

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 120

Ashish M. Kamat

Ashish M. Kamat

The University of Texas MD Anderson Cancer Center

Publications: 118

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 113

Jelle O. Barentsz

Jelle O. Barentsz

Radboud University Nijmegen

Publications: 109

Jianfeng Xu

Jianfeng Xu

NorthShore University HealthSystem

Publications: 104

Baris Turkbey

Baris Turkbey

National Institutes of Health

Publications: 103

Peter L. Choyke

Peter L. Choyke

National Institutes of Health

Publications: 102

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 102

Arnulf Stenzl

Arnulf Stenzl

University of Tübingen

Publications: 99

Lambertus A. Kiemeney

Lambertus A. Kiemeney

Radboud University Nijmegen

Publications: 97

Mark Emberton

Mark Emberton

University College London

Publications: 81

Colin P. Dinney

Colin P. Dinney

The University of Texas MD Anderson Cancer Center

Publications: 78

Trending Scientists

Mohamed Abdel-Mottaleb

Mohamed Abdel-Mottaleb

University of Miami

Tuvi Etzion

Tuvi Etzion

Technion – Israel Institute of Technology

Martha E. Pollack

Martha E. Pollack

Cornell University

Robin Smith

Robin Smith

University of Manchester

Henri Brunner

Henri Brunner

University of Regensburg

Stanford R. Ovshinsky

Stanford R. Ovshinsky

Energy Conversion Devices

René Feyereisen

René Feyereisen

University of Copenhagen

Maria Martinez

Maria Martinez

Inserm : Institut national de la santé et de la recherche médicale

Pawel Stankiewicz

Pawel Stankiewicz

Baylor College of Medicine

André Aptroot

André Aptroot

Federal University of Mato Grosso do Sul

Guy G. Poirier

Guy G. Poirier

Université Laval

Si-Chee Tsay

Si-Chee Tsay

Goddard Space Flight Center

Charles Kornreich

Charles Kornreich

Université Libre de Bruxelles

Charles M. Rudin

Charles M. Rudin

Memorial Sloan Kettering Cancer Center

Jeckoniah O. Ndinya-Achola

Jeckoniah O. Ndinya-Achola

University of Nairobi

Barry Hindess

Barry Hindess

Australian National University

Something went wrong. Please try again later.